Amyloid-β25-35 induces apolipoprotein D synthesis and growth arrest in HT22 hippocampal cells

Journal of Alzheimer's Disease

Volumn 30, Issue 2, 2012, Pages 233-244

  Martínez, Eva ^a   Navarro, Ana ^a   Ordóez, Cristina ^b   Del Valle, Eva ^a   Tolivia, Jorge ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Alzheimer's disease; apolipoprotein D; growth arrest; HT22; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; APOLIPOPROTEIN D; RECOMBINANT APOLIPOPROTEIN D; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIPID TRANSPORT; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; UPREGULATION;

EID: 84861565114     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-112102     Document Type: Article

References (71)

1. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7, 548-554. (Pubitemid 33127140)
2. Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid beta in Alzheimer's disease. Prog Neurobiol 83, 131-139. (Pubitemid 47484046)
3. Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43, 658-677. (Pubitemid 47102132)
4. Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adh Migr 3, 88-93.
5. Varadarajan S, Yatin S, Aksenova M, Butterfield DA (2000) Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130, 184-208.
6. Bulbarelli A, Lonati E, Cazzaniga E, Re F, Sesana S, Barisani D, Sancini G, Mutoh T, Masserini M (2009) TrkA pathway activation induced by amyloid-beta (Abeta). Mol Cell Neu-rosci 40, 365-373.
7. Vogt M, Skerra A (2001) Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J Mol Recognit 14, 79-86.
8. Eichinger A, Nasreen A, Kim HJ, Skerra A (2007) Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J Biol Chem 282, 31068-31075. (Pubitemid 350035183)
9. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Ter-risse L, Milne R (2000) Apolipoprotein D. Biochim Biophys Acta 1482, 185-198.
10. Boyles JK, Notterpek LM, Wardell MR, Rall SC Jr (1990) Identification, characterization, and tissue distribution of apolipoprotein D in the rat. J Lipid Res 31, 2243-2256.
11. Provost PR, Villeneuve L, Weech PK, Milne RW, Marcel YL, Rassart E (1991) Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J Lipid Res 32, 1959-1970.
12. Seguin D, Desforges M, Rassart E (1995) Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Brain Res Mol Brain Res 30, 242-250.
13. Sanchez D, Ganfornina MD, Martinez S (2002) Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech Dev 110, 225-229.
14. Ganfornina MD, Sanchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martinez S (2005) Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: Implications for the evolution of vertebrate lipocalins. Dev Dyn 232, 191-199. (Pubitemid 40070871)
15. Ganfornina MD, Do Carmo S, Martinez E, Tolivia J, Navarro A, Rassart E, Sanchez D (2010) Apo D, an apolipoprotein expressed by Schwann cells, is required for peripheral nerve functional integrity and a timely response to injury. GLIA 58, 1320-1334.
16. Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, Olek K, Muller HW (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibro-blasts of peripheral nerve. EMBO J 9, 2479-2484.
17. Hu CY, Ong WY, Sundaram RK, Chan C, Patel SC (2001) Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. J Neurocytol 30, 209-218.
18. Navarro A, Del Valle E, Tolivia J (2004) Differential expression of apolipoprotein d in human astroglial and oligo-dendroglial cells. J Histochem Cytochem 52, 1031-1036. (Pubitemid 38982191)
19. Navarro A, Del Valle E, Juarez A, Martinez E, Ordonez C, Astudillo A, Tolivia J (2010) Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan. Age (Dordr) 32, 85-96.
20. Perez C, Navarro A, Martinez E, Ordonez C, Del Valle E, Tolivia J (2011) Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment. Age (Dordr), doi: 10.1007/s11357-011- 9286-5.
21. Do Carmo S, Jacomy H, Talbot PJ, Rassart E (2008) Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 28, 10330-10338.
22. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (2008) Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: Influence of enriched environment. J Cereb Blood Flow Metab 28, 551-562. (Pubitemid 351304266)
23. Thomas EA, Copolov DL, Sutcliffe JG (2003) From phar-macotherapy to pathophysiology: Emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr Mol Med 3, 408-418. (Pubitemid 36975100)
24. Suresh S, Yan Z, Patel RC, Patel YC, Patel SC (1998) Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem 70, 242-251. (Pubitemid 28020849)
25. Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisen-hammer F, Berger T (2001) Increased intrathecal production of apolipoprotein D in multiple sclerosis. J Neuroimmunol 119, 327-332. (Pubitemid 32918341)
26. Belloir B, Kovari E, Surini-Demiri M, Savioz A (2001) Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 64, 61-69. (Pubitemid 32267994)
27. Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN (2003) Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: No relation to apolipoprotein E expression or genotype. Biol Psychiatry 54, 136-141. (Pubitemid 36859773)
28. Ordoñez C, Navarro A, Perez C, Martinez E, del Valle E, Tolivia J (2012) Gender differences in apolipoprotein D expression during aging and in Alzheimer disease. Neurobiol Aging 33, 433. e11-e20.
29. Thomas EA, Sautkulis LN, Criado JR, Games D, Sutcliffe JG (2001) Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J Neurochem 79, 1059-1064. (Pubitemid 33117086)
30. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI (2005) Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques inAlzheimer's disease temporal cortex. Neurobiol Dis 20, 574-582. (Pubitemid 41476283)
31. del Valle E, Navarro A, Astudillo A, Tolivia J (2003) Apolipoprotein D expression in human brain reactive astro-cytes. J Histochem Cytochem 51, 1285-1290. (Pubitemid 37187580)
32. Navarro A, Astudillo A, del Valle E, Gonzalez del Rey C, Tolivia J (2001) Immunohistochemical presence of apolipoprotein D in senile plaques. J Histotech 24, 45-48. (Pubitemid 32268522)
33. Navarro A, Del Valle E, Astudillo A, Gonzalez del Rey C, Tolivia J (2003) Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol 184, 697-704. (Pubitemid 38182798)
34. DoCarmo S, Seguin D, Milne R, Rassart E (2002) Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277, 5514-5523. (Pubitemid 34968602)
35. Sarjeant JM, Lawrie A, Kinnear C, Yablonsky S, Leung W, Massaeli H, Prichett W, Veinot JP, Rassart E, Rabinovitch M (2003) Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Arterioscler Thromb Vasc Biol 23, 2172-2177. (Pubitemid 37532316)
36. Do Carmo S, Levros LC Jr, Rassart E (2007) Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 1773, 954-969. (Pubitemid 46839140)
37. Lambert J, Provost PR, Marcel YL, Rassart E (1993) Structure of the human apolipoproteinDgene promoter region. Biochim Biophys Acta 1172, 190-192. (Pubitemid 23065802)
38. Levros LC Jr, Carmo SD, Edouard E, Legault P, Charfi C, Ras-sart E (2010) Characterization of nuclear factors modulating the apolipoprotein D promoter during growth arrest: Implication of PARP-1, APEX-1 and ERK1/2 catalytic activities. Biochim Biophys Acta 1803, 1062-1071.
39. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, Ganfornina MD (2006) Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr Biol 16, 680-686.
40. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, Gonzalez C, Bastiani MJ, Rassart E, Sanchez D (2008) Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 7, 506-515. (Pubitemid 351998611)
41. Ruiz M, Sanchez D, Canal I, Acebes A, Ganfornina MD (2011) Sex-dependent modulation of longevity by two Drosophila homologues of human Apolipoprotein D, GLaz and NLaz. Exp Gerontol 46, 579-589.
42. Bajo-Graneras R, Ganfornina MD, Martin-Tejedor E, Sanchez D (2011) Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia 59, 1551-1566.
43. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
44. Ordoñez C, Navarro A, Perez C, Astudillo A, Martinez E, Tolivia J (2006) Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 21, 361-366.
45. Navarro A, Ordonez C, Martinez E, Perez C, Astudillo A, Tolivia J (2008) Apolipoprotein D expression absence in degeneratingneuronsofhuman central nervoussystem. Histol Histopathol 23, 995-1001.
46. Tolivia J, Navarro A, del Valle E, Perez C, Ordonez C, Martinez E (2006) Application of Photoshop and Scion Image analysis to quantification of signals in histochem-istry, immunocytochemistry and hybridocytochemistry. Anal Quant Cytol Histol 28, 43-53. (Pubitemid 43334519)
47. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92, 9363-9367.
48. Glockner F, Ohm TG (2003) Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuro-science 122, 103-110. (Pubitemid 37329950)
49. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278, 11612-11622. (Pubitemid 36792723)
50. Yagami T, Ueda K, Sakaeda T, Itoh N, Sakaguchi G, Okamura N, Hori Y, Fujimoto M (2004) Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol 67, 1153-1165. (Pubitemid 38296794)
51. Wernyj RP, Mattson MP, Christakos S (1999) Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Brain Res Mol Brain Res 64, 69-79. (Pubitemid 29049237)
52. Zhang HY, Liu YH, Wang HQ, Xu JH, Hu HT (2008) Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int 32, 1230-1237.
53. Lee WS, Tsai WJ, Yeh PH, Wei BL, Chiou WF (2006) Divergent role of calcium on Abeta-and MPTP-induced cell death in SK-N-SH neuroblastoma. Life Sci 78, 1268-1275.
54. Sung YJ, Cheng CL, Chen CS, Huang HB, Huang FL, Wu PC, Shiao MS, Tsay HJ (2003) Distinct mechanisms account for beta-amyloid toxicity in PC12 and differentiated PC12 neuronal cells. J Biomed Sci 10, 379-388.
55. Feng Z, Zhang JT (2004) Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells. J Pineal Res 37, 257-266. (Pubitemid 39457047)
56. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z (2010) Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 57, 547-555.
57. Butterfield DA, Galvan V, Lange MB, Tang H, Sowell RA, Spilman P, Fombonne J, Gorostiza O, Zhang J, Sultana R, Bredesen DE (2010) In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med 48, 136-144.
58. Gillardon F, Skutella T, Uhlmann E, Holsboer F, Zimmermann M, Behl C (1996) Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity. Brain Res 706, 169-172. (Pubitemid 26031109)
59. Lopez-Boado YS, Klaus M, Dawson MI, Lopez-Otin C (1996) Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway. J Biol Chem271, 32105-32111. (Pubitemid 26422241)
60. Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E (1991) Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett 290, 139-141.
61. Lopez-Boado YS, Tolivia J, Lopez-Otin C (1994) Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J Biol Chem 269, 26871-26878. (Pubitemid 24332885)
62. DoCarmo S, Fournier D, Mounier C, Rassart E (2009) Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am J Physiol Endocrinol Metab 296, E802-E811.
63. Perdomo G, Dong HH (2009) Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging 1, 17-27.
64. Alvarez ML, Barbon JJ, Gonzalez LO, Abelairas J, Boto A, Vizoso FJ (2003) Apolipoprotein D expression in retinoblas-toma. Ophthalmic Res 35, 111-116.
65. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932. (Pubitemid 26171198)
66. He X, Jittiwat J, Kim JH, Jenner AM, Farooqui AA, Patel SC, Ong WY (2009) Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury. Neurosci Lett 455, 183-186.
67. Kim WS, Wong J, Weickert CS, Webster MJ, Bahn S, Garner B (2009) Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. J Neurochem 109, 1053-1066.
68. Zhang Y, Cong Y, Wang S, Zhang S (2011) Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D. Mol Biol Rep 38, 1847-1851.
69. Bajo-Graneras R, Sanchez D, Gutierrez G, Gonzalez C, Do Carmo S, Rassart E, Ganfornina MD (2011) Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J Neurochem 117, 949-960.
70. Nasreen A, Vogt M, Kim HJ, Eichinger A, Skerra A (2006) Solubility engineering and crystallization of human apolipoprotein D. Protein Sci 15, 190-199. (Pubitemid 43004246)
71. Perdomo G, Kim DH, Zhang T, Qu S, Thomas EA, Toledo FG, Slusher S, Fan Y, Kelley DE, Dong HH (2010) A role of apolipoprotein D in triglyceride metabolism. J Lipid Res 51, 1298-1311.